UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation

Radiographics, 2020-05, Vol.40 (3), p.656-666

2020

Volltextzugriff (PDF)

Socially Oriented Approaches in Cities—Hasanpasa Gasworks and Gasworks Environmental Volunteers

Sustainability, 2023-09, Vol.15 (17), p.12924

2023

Volltextzugriff (PDF)

Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics features

European radiology, 2022-06, Vol.32 (6), p.4025-4033

2022

Volltextzugriff (PDF)

Abdominal and pelvic splenosis: atypical findings, pitfalls, and mimics

Abdominal radiology (New York), 2022-03, Vol.47 (3), p.923-947

2022

Volltextzugriff (PDF)

Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.229-229

2021

Volltextzugriff (PDF)

Primary splenic lymphoma on top of intrahepatic splenosis: A unique case report

Radiology case reports, 2022-08, Vol.17 (8), p.2850-2854

2022

Volltextzugriff (PDF)

Combined modality PET/MR for the detection of severe large vessel vasculitis

European journal of hybrid imaging, 2022-08, Vol.6 (1), p.16-16, Article 16

2022

Volltextzugriff (PDF)

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Blood, 2021-03, Vol.137 (10), p.1318-1326

2021

Volltextzugriff (PDF)

Thyroid Scintigraphy and Therapy in the Setting of Hyperthyroidism: Review of a “Hot” Topic

MedEdPORTAL, 2014-02, Vol.10

2014

Volltextzugriff (PDF)

Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis

Journal of rheumatology, 2021-12, Vol.48 (12), p.1830

2021

Volltextzugriff (PDF)

PD50-07 PET PSMA IMAGING FOR EVALUATION OF RECURRENT OR PERSISTENT PROSTATE CANCER AFTER PRIMARY PROSTATE RADIATION

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

The utility of [ 18 F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate-Resistant Prostate Cancer Patients (nmCRPCp): diagnostic performance and impact on management

British journal of radiology, 2023-12, Vol.96 (1152), p.20230414-20230414

2023

Volltextzugriff (PDF)

FLIPI-3: A New PET-Based Prognostic Index for Follicular Lymphoma Based on Results from a Validation Study with the ECOG-ACRIN E2408 Cohort

Blood, 2022-11, Vol.140 (Supplement 1), p.6480-6481

2022

Volltextzugriff (PDF)

Utility of minimally invasive thoracoscopy for assessment of residual mediastinal lymphoma

Surgery, 2018-10, Vol.164 (4), p.825-830

2018

Volltextzugriff (PDF)

Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis

Blood, 2021-11, Vol.138 (Supplement 1), p.231-231

2021

Volltextzugriff (PDF)

Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system

The Prostate, 2024-06, Vol.84 (8), p.717-722

2024

Volltextzugriff (PDF)

Extraosseous Findings on Bone Scintigraphy Using Fusion SPECT/CT and Correlative Imaging

American journal of roentgenology (1976), 2015-07, Vol.205 (1), p.160

2015

Volltextzugriff (PDF)

RATE AND OUTCOMES OF SNMMI “RARELY APPROPRIATE” PSMA PET/CT SCAN USE IN INITIAL STAGING AND BIOCHEMICALLY RECURRENT PROSTATE CANCER

Urologic oncology, 2024-03, Vol.42, p.S77-S78

2024

Volltextzugriff (PDF)

ROLE OF T99MDP BONE SCAN AND AXIAL IMAGING IN THE PET PSMA ERA FOR INITIAL STAGING OF NEWLY DIAGNOSED PROSTATE CANCER

Urologic oncology, 2024-03, Vol.42, p.S78-S78

2024

Volltextzugriff (PDF)

FACTORS ASSOCIATED WITH PSMA POSITIVITY AT LOW PSA AFTER RADICAL PROSTATECTOMY

Urologic oncology, 2024-03, Vol.42, p.S87-S87

2024

Volltextzugriff (PDF)

A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging

Seminars in nuclear medicine, 2024-01, Vol.54 (1), p.119-131

2024

Volltextzugriff (PDF)

Frequent Monitoring of A1C During Pregnancy as a Treatment Tool to Guide Therapy

Diabetes care, 2011-01, Vol.34 (1), p.53-54

2011

Volltextzugriff (PDF)

Multimodality imaging findings of infection-induced tumors

Abdominal radiology (New York), 2022-11, Vol.47 (11), p.3930-3953

2022

Volltextzugriff (PDF)

A Phase II StudyÂ of Sequential Pembrolizumab (PEM)Â FollowedÂ By AVD for Frontline TreatmentÂ of Classical Hodgkin Lymphoma (CHL): Quantifying Response FollowingÂ PEM MonotherapyÂ with FDG-PET-Derived Metabolic Tumor Volume and Total Lesion Glycolysis

Blood, 2018-11, Vol.132 (Supplement 1), p.1651-1651

2018

Volltextzugriff (PDF)

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Blood, 2019-11, Vol.134 (Supplement_1), p.4029-4029

2019

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(75)
Humans
(48)
Male
(40)
Female
(34)
Adult
(21)
Middle Aged
(15)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Rheumatology
(13)
Aged
(12)
Medicine
(10)
Adolescent
(9)
Animals
(9)
Medicine & Public Health
(9)
Retrospective Studies
(9)
Turkey
(9)
Child
(8)
Young Adult
(8)
Eğitim Bilimleri
(7)
Magnetic Resonance Imaging
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation

Socially Oriented Approaches in Cities—Hasanpasa Gasworks and Gasworks Environmental Volunteers

Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics features

Abdominal and pelvic splenosis: atypical findings, pitfalls, and mimics

Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial

Primary splenic lymphoma on top of intrahepatic splenosis: A unique case report

Combined modality PET/MR for the detection of severe large vessel vasculitis

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Thyroid Scintigraphy and Therapy in the Setting of Hyperthyroidism: Review of a “Hot” Topic

Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis

PD50-07 PET PSMA IMAGING FOR EVALUATION OF RECURRENT OR PERSISTENT PROSTATE CANCER AFTER PRIMARY PROSTATE RADIATION

The utility of [ 18 F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate-Resistant Prostate Cancer Patients (nmCRPCp): diagnostic performance and impact on management

FLIPI-3: A New PET-Based Prognostic Index for Follicular Lymphoma Based on Results from a Validation Study with the ECOG-ACRIN E2408 Cohort

Utility of minimally invasive thoracoscopy for assessment of residual mediastinal lymphoma

Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis

Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system

Extraosseous Findings on Bone Scintigraphy Using Fusion SPECT/CT and Correlative Imaging

RATE AND OUTCOMES OF SNMMI “RARELY APPROPRIATE” PSMA PET/CT SCAN USE IN INITIAL STAGING AND BIOCHEMICALLY RECURRENT PROSTATE CANCER

ROLE OF T99MDP BONE SCAN AND AXIAL IMAGING IN THE PET PSMA ERA FOR INITIAL STAGING OF NEWLY DIAGNOSED PROSTATE CANCER

FACTORS ASSOCIATED WITH PSMA POSITIVITY AT LOW PSA AFTER RADICAL PROSTATECTOMY

A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging

Frequent Monitoring of A1C During Pregnancy as a Treatment Tool to Guide Therapy

Multimodality imaging findings of infection-induced tumors

A Phase II StudyÂ of Sequential Pembrolizumab (PEM)Â FollowedÂ By AVD for Frontline TreatmentÂ of Classical Hodgkin Lymphoma (CHL): Quantifying Response FollowingÂ PEM MonotherapyÂ with FDG-PET-Derived Metabolic Tumor Volume and Total Lesion Glycolysis

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Suchergebnisse filtern